Cardiovascular Research Centre (CVRC)
Cardiovascular diseases such as arrhythmias, myocardial infarction and heart failure are the most common cause of death in the industrialised Western world and the cost for the society and the health care system to treat cardiovascular diseases is tremendous. It is of main importance to strengthen research activities to identify new mechanisms, risk factors and new target principles for more effective diagnosis, treatment and prevention of cardiovascular diseases.
About
Environment information
Contact
Research Domains
- Medicine
Areas of Research
- Biomedicine
- Cirkulation
- Haemostasis
- Immunology
- Inflammation
- Cardiology
- Medicine
- Microbiology
The Cardiovascular Research Centre (CVRC) research environment is a network of approximately 40 members at Örebro University and Örebro University Hospital/Region Örebro County working with basic, translational and clinical research to identify new mechanisms, risk factors and new target principles for more effective diagnosis, treatment and prevention of cardiovascular diseases. The CVRC was founded in 2014 and the overall strategy is to support internal and external academic and industrial research collaboration and to contribute to a successful and high-quality third cycle education in the field of cardiovascular research. The CVRC has been ranked as a strong research environment by external evaluators.
Researchers
Researchers
- Torbjörn Bengtsson
- Cecilia Bergh
- Dick Delbro
- Gabriella Eliason
- Karin H Franzén
- Ole Fröbert
- Knut Fälker
- Magnus Grenegård
- Hans Hjelmqvist
- Anita Hurtig-Wennlöf
- Hazem Khalaf
- Ashok Kumawat
- Liza Ljungberg
- Eva Oskarsson
- Eleonor Palm
- Geena Paramel
- Sofia Ramström
- Dirk Repsilber
- Allan Sirsjö
- Madelene Lindkvist, PhD student
- Mulugeta Melkie Zegeye, PhD student
- Abubakr Omer, PhD student
- Sukithar Rajan, PhD student
Research Teams
Research Projects
Research Projects
- Leukocytes in periodontitis
- Bacteriocins in prevention and treatment of infections
- Connection between primary and secondary hemostasis
- Cross-talk between platelets and the vessel wall
- Gingival fibroblasts as immune cells in periodontitis
- Inflammation and lipids in vascular disease
- Interleukin-6 as a therapeutic target for atherosclerosis
- Lactobacilli and bacteriocins in prevention and treatment of periodontitis, peri-implantitis and systemic inflammation
- Lifestyle, Biomarkers, and Atherosclerosis (LBA) Study
- Link between primary hemostasis and inflammation
- Lipoprotein profile in periodontitis and its role in cardiovascular disease
- Network medicine and systems biological approaches to modeling inflammation
- Plastic antibodies and nanoplasmonic sensors in targeting risk markers of periodontitis and cardiovascular disease
- Role of the NLRP3 inflammasome in cardiovascular disease
- Role of zinc finger proteins in cardiovascular diseases and cancer
- T-cells in periodontitis
- The effects of periodontal pathogens on gene and protein expression in vascular smooth muscle cells
- The role of platelets in sensing bacterial infection and causing inflammation
News & Media
-
Örebro researchers show how a peptide can render antibiotics effective again – at doses 100 times lower than usual
A peptide renders older antibiotics effective again at doses 100 times lower than the common dosage, as shown by research from Örebro University. Lower doses of antibiotics in turn reduces the risk of further development of antibiotic resistance.
-
Örebroforskning ska ge bättre vård för patienter med acne och rosacea
Tre forskare med koppling till Örebro universitet får medel från Vinnova för sin innovation som kan ge bättre vård för patienter med acne och rosacea.
-
Örebro University once again high on list of world’s best universities
Örebro University is in place 405 when Times Higher Education ranks the world’s best universities – thanks to high quality research and a high degree of citations.
Source of external research funding - current and previous
